2024    2023    2022    2021    2020    2019    2018    2017    2016   

2018

Articles

1 - 

Facial emotion recognition in Parkinson's disease A review and new hypotheses

Soizic Argaud, Marc Vérin, Paul Sauleau, Didier Grandjean

Movement Disorders, 2018, 33 (4), pp.554-567.

DOI : https://doi.org/10.1002/mds.27305

Pubmed : 29473661

 

2 - 

Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease Clinical Relevance

Manon Auffret, Sophie Drapier, Marc Vérin

Clinical Drug Investigation, 2018, 38 (4), pp.287-312.

DOI : https://doi.org/10.1007/s40261-018-0619-3

Pubmed : 29327219

 

3 - 

The Many Faces of Apomorphine Lessons from the Past and Challenges for the Future

Manon Auffret, Sophie Drapier, Marc Vérin

Drugs in R&D, 2018, 18 (2), pp.91-107.

DOI : https://doi.org/10.1007/s40268-018-0230-3

Pubmed : 29546602

 

4 - 

The Many Faces of Apomorphine Lessons from the Past and Challenges for the Future (vol 18, pg 91, 2018)

Manon Auffret, Sophie Drapier, Marc Vérin

Drugs in R&D, 2018, 18 (2), pp.161-161.

DOI : https://doi.org/10.1007/s40268-018-0233-0

Pubmed : 29737467

 

5 - 

Data-Driven Prediction of the Therapeutic Window during Subthalamic Deep Brain Stimulation Surgery

Clement Baumgarten, Claire Haegelen, Yulong Zhao, Paul Sauleau, Pierre Jannin

Stereotactic and Functional Neurosurgery, 2018, 96 (3), pp.142-150.

DOI : https://doi.org/10.1159/000488683

Pubmed : 30032132

 

6 - 

Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

Mathieu Ceccaldi, Thérèse Jonveaux, Antoine Verger, Pierre Krolak-Salmon, Claire Houzard, Olivier Godefroy, Trevor Shields, Audrey Perrotin, Rossella Gismondi, Santiago Bullich et al.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018, 14 (3), pp.293-305.

DOI : https://doi.org/10.1016/j.jalz.2017.09.009

Pubmed : 29107051

 

7 - 

Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease

Joan Duprez, Jean-François Houvenaghel, Sophie Drapier, Manon Auffret, Dominique Drapier, Gabriel Robert, Marc Vérin, Paul Sauleau

Journal of Neurology, 2018, 265 (3), pp.471-477.

DOI : https://doi.org/10.1007/s00415-017-8721-7

Pubmed : 29285653

 

8 - 

Functional atlases for analysis of motor and neuropsychological outcomes after medial globus pallidus and subthalamic stimulation

Claire Haegelen, Clement Baumgarten, Jean-François Houvenaghel, Yulong Zhao, Julie Peron, Sophie Drapier, Pierre Jannin, Xavier Morandi

PLoS ONE, 2018, 13 (7), pp.e0200262.

DOI : https://doi.org/10.1371/journal.pone.0200262

Pubmed : 30005077

 

9 - 

Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life

Jean-François Houvenaghel, Sophie Drapier, Joan Duprez, Gabriel Hadrien Robert, Audrey Riou, Dominique Drapier, Paul Sauleau, Marc Vérin

Journal of the Neurological Sciences, 2018, 395, pp.113-118.

DOI : https://doi.org/10.1016/j.jns.2018.10.010

Pubmed : 30312901

 

10 - 

French guidelines on stereoelectroencephalography (SEEG)

Jean Isnard, Delphine Taussig, Fabrice Bartolomei, Pierre Bourdillon, Hélène Catenoix, Francine Chassoux, Mathilde Chipaux, Stéphane Clemenceau, Sophie Colnat-Coulbois, Marie Denuelle et al.

Neurophysiologie Clinique = Clinical Neurophysiology, 2018, 48 (1), pp.5-13. ⟨hal-01744390v2⟩

DOI : https://doi.org/10.1016/j.neucli.2017.11.005

Pubmed : 29277357